The 20-acre integrated R&D and GMP manufacturing campus includes 1 R&D center accommodating 800+ scientists , 4 plants and 6 finishing areas, including high potency R&D labs & plants, and an enzyme fermentation plant.
The site supports various API enabling technologies, such as crystallization & particle engineering, biocatalysis, continuous manufacturing (flow chemistry), chemo-catalysis and large scale prep-HPLC & SFC.
Shanghai Jinshan site is about 2-hour driving distance to Wuxi city site (drug product site) and Changzhou site (API site) which enables seamless collaborations between API teams and formulation teams for efficient, flexible, and high-quality solutions to global pharma and biotech customers.
Jinshan site has successfully passed inspections by US FDA, EMA, China NMPA, Japan PMDA, South Korean MFDS, Brazil ANVISA several times since 2013.
